 |
| The Trypsin Market |
Trypsin is a proteolytic enzyme which breaks down proteins. It is commonly used in medical applications such as dissociation of mammalian cells for viral production, culture initiation, tissue dissociation, and isolation of intracellular components from tissue cultures. The growing biopharmaceutical industry is fueling the demand for trypsin. Trypsin breaks down the proteins on the surface of cells allowing researchers to harvest individual cells for analysis.
The global
Trypsin Market is estimated to be valued at US$ 46.72 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The strong growth of the trypsin market is attributed to the increasing demand
from various medical applications. One of the key trends in the market is the
growing adoption of single-use bioprocessing technologies in biopharmaceutical
manufacturing. Single-use bioprocessing involves using disposable plastic bags,
tubing, filters, and other components instead of conventional stainless steel
equipment. This has significantly reduced production timelines and
manufacturing costs. In the biopharmaceutical industry, single-use technologies
use trypsin for cell harvesting applications. The biopharmaceutical manufacturers
are shifting towards single-use technologies due to their advantages such as
reduced capital investment and faster implementation of processes. Thus, the
rising usage of single-use technologies in biopharmaceutical production is
fueling the demand for trypsin, driving the market growth over the forecast
period.
Segment Analysis
The global trypsin market is segmented by type, application, end user, and
geography. By type, the pancreatic trypsin segment dominated the market and
accounted for the largest revenue share in 2023. Pancreatic trypsin is majorly
used in proteomic studies to aid protein extraction from various biological
samples such as tissues and cells. It is also used in biochemical research as a
digestive enzyme.
Key Takeaways
The global Trypsin
Market Growth is estimated to be valued at US$ 46.72 Mn in 2023 and is
expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030.
Regional analysis: North America accounted for the maximum share of the global
trypsin market in 2023. The presence of many established market players,
advanced healthcare infrastructure, and rising research activities are fueling
market growth in the region. Asia Pacific is anticipated to witness the fastest
growth during the forecast period owing to rapidly growing healthcare industry,
rising drug discovery activities, and increasing incidence of chronic diseases
in the region.
Key players: The global trypsin market is consolidated in nature with a few
dominating players accounting for major market share. Key players operating in
the trypsin market are Pfizer, Inc., GlaxoSmithKline, Merck & Co., Inc.,
Johnson & Johnson. Pfizer, Inc. dominated the global market in 2023 owing
to its strong brand presence and wide distribution network for proteolytic enzymes
across major markets. The company offers various trypsin products such as
ultrapure grade trypsin and sequencing grade modified trypsin.
For more insights, read- https://www.newsanalyticspro.com/trypsin-market-trends-size-and-share-analysis/
For more details on the report, Read- https://www.shayaricenter.com/natures-barcodes-biomarkers-illuminate-paths-to-wellness-and-scientific-breakthroughs
0 Comments